Alkem Laboratories Limited (ALKEM.NS)
INR 4828.7
(-2.87%)
INR 4828.7
(-2.87%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 400 Million INR | -43.13% |
| 2022 | 703.3 Million INR | -7.28% |
| 2021 | 758.5 Million INR | 121.46% |
| 2020 | 342.5 Million INR | -78.49% |
| 2019 | 1.59 Billion INR | -31.15% |
| 2018 | 2.31 Billion INR | 76.93% |
| 2017 | 1.3 Billion INR | -37.4% |
| 2016 | 2.08 Billion INR | 69.16% |
| 2015 | 1.23 Billion INR | 220.09% |
| 2014 | 385.7 Million INR | -28.47% |
| 2013 | 539.23 Million INR | -41.57% |
| 2012 | 922.84 Million INR | -27.44% |
| 2011 | 1.27 Billion INR | -82.62% |
| 2010 | 7.31 Billion INR | 952.13% |
| 2009 | 695.46 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 1.81 Billion INR | 0.0% |
| 2023 FY | 400 Million INR | -43.13% |
| 2023 Q4 | 400 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 703.3 Million INR | -7.28% |
| 2022 Q2 | 822.3 Million INR | 0.0% |
| 2022 Q4 | 703.3 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 758.5 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 87.2 Million INR | 0.0% |
| 2021 FY | 758.5 Million INR | 121.46% |
| 2020 FY | 342.5 Million INR | -78.49% |
| 2020 Q2 | 1.3 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 342.5 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 3.33 Billion INR | 0.0% |
| 2019 FY | 1.59 Billion INR | -31.15% |
| 2019 Q4 | 1.59 Billion INR | 0.0% |
| 2018 FY | 2.31 Billion INR | 76.93% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q4 | 2.31 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 1.98 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 FY | 1.3 Billion INR | -37.4% |
| 2017 Q4 | 1.3 Billion INR | 0.0% |
| 2017 Q2 | 2.63 Billion INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 Q4 | 2.08 Billion INR | 0.0% |
| 2016 Q2 | 1.31 Billion INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 FY | 2.08 Billion INR | 69.16% |
| 2016 Q3 | - INR | -100.0% |
| 2015 Q4 | 1.23 Billion INR | 0.0% |
| 2015 Q2 | 774.4 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 1.23 Billion INR | 220.09% |
| 2014 FY | 385.7 Million INR | -28.47% |
| 2014 Q4 | 385.7 Million INR | 0.0% |
| 2014 Q1 | - INR | 0.0% |
| 2013 FY | 539.23 Million INR | -41.57% |
| 2012 FY | 922.84 Million INR | -27.44% |
| 2011 FY | 1.27 Billion INR | -82.62% |
| 2010 FY | 7.31 Billion INR | 952.13% |
| 2009 FY | 695.46 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aarti Drugs Limited | 2.75 Billion INR | 85.472% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -99900.0% |
| Albert David Limited | 6.01 Million INR | -6548.936% |
| Alembic Pharmaceuticals Limited | 628.8 Million INR | 36.387% |
| Bafna Pharmaceuticals Limited | 107.53 Million INR | -271.982% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| FDC Limited | 2.46 Million INR | -16120.6% |
| Gufic Biosciences Limited | 1.53 Billion INR | 74.02% |
| Hikal Limited | 4.22 Billion INR | 90.54% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -258.339% |
| Ind-Swift Limited | 10.09 Billion INR | 96.038% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 98.737% |
| Lincoln Pharmaceuticals Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -199.533% |
| Medico Remedies Limited | 8.67 Million INR | -4512.546% |
| Morepen Laboratories Limited | 33.64 Million INR | -1089.061% |
| Nectar Lifesciences Limited | 1.4 Billion INR | 71.491% |
| Orchid Pharma Limited | 1.2 Billion INR | 66.786% |
| Procter & Gamble Health Limited | 68.8 Million INR | -481.395% |
| RPG Life Sciences Limited | -30.3 Million INR | 1420.132% |
| Alembic Limited | 73.9 Million INR | -441.272% |
| Bajaj HealthCare Limited | 650.34 Million INR | 38.494% |
| Brooks Laboratories Limited | 3.56 Million INR | -11120.196% |
| Eris Lifesciences Limited | 6.54 Billion INR | 93.889% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -170.984% |
| Sigachi Industries Limited | 265.79 Million INR | -50.49% |
| Solara Active Pharma Sciences Limited | 1.17 Billion INR | 65.94% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -2907.519% |
| Innova Captab Limited | 2.1 Billion INR | 80.999% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -88.363% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -429.311% |
| Themis Medicare Limited | 267.74 Million INR | -49.399% |
| Unichem Laboratories Limited | 382.22 Million INR | -4.651% |
| Vaishali Pharma Limited | 35.98 Million INR | -1011.636% |
| Venus Remedies Limited | 386.8 Million INR | -3.413% |
| Wanbury Limited | 820 Million INR | 51.22% |
| Windlas Biotech Limited | 20.18 Million INR | -1882.161% |
| ZIM Laboratories Limited | 356 Million INR | -12.358% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Lupin Limited | 1.55 Billion INR | 74.24% |
| Sakar Healthcare Limited | 549.55 Million INR | 27.213% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 98.126% |
| Divi's Laboratories Limited | 20 Million INR | -1900.0% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -1336.988% |
| Mankind Pharma Limited | 325.81 Million INR | -22.769% |
| Sequent Scientific Limited | 1.42 Billion INR | 71.973% |
| Laurus Labs Limited | 7.98 Billion INR | 94.989% |
| Neuland Laboratories Limited | 449.2 Million INR | 10.954% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -69.205% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | 73.631% |
| Zydus Lifesciences Limited | 251 Million INR | -59.363% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -2763.688% |
| Wockhardt Limited | 8.91 Billion INR | 95.511% |
| Bal Pharma Limited | 363.82 Million INR | -9.943% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 93.322% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -12.384% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 9.2 Million INR | -4247.826% |
| Shilpa Medicare Limited | 5.6 Billion INR | 92.859% |
| Valiant Laboratories Limited | 750.89 Million INR | 46.731% |
| Ajanta Pharma Limited | 235.2 Million INR | -70.068% |
| Hester Biosciences Limited | 1.81 Billion INR | 77.995% |
| Aarey Drugs & Pharmaceuticals Limited | 32.24 Million INR | -1140.55% |
| Granules India Limited | 689.71 Million INR | 42.005% |
| Medicamen Biotech Limited | 12.55 Million INR | -3085.982% |
| Ipca Laboratories Limited | 5.8 Billion INR | 93.108% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 32913.782% |
| Piramal Enterprises Limited | 535.85 Billion INR | 99.925% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 97.506% |
| NATCO Pharma Limited | 53 Million INR | -654.717% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | 78.202% |
| Strides Pharma Science Limited | 6.71 Billion INR | 94.043% |
| Indoco Remedies Limited | 3.51 Billion INR | 88.628% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -275.235% |